公开(公告)号：US12024452B2

公开(公告)日：2024-07-02

申请号：US17878258

申请日：2022-08-01

Applicant: University of Houston System

Inventor： Jeffrey D. Rimer ,  Xi Geng ,  Ricardo Sosa

IPC: C02F5/10

CPC classification number: C02F5/10

Abstract: Analogues of citrate, namely hydroxycitrate (HCA) and isocitrate (ICA), have dual roles as nucleation inhibitors and growth suppressors in the formation of mineral scale. Their potency is comparable to commercial phosphorous-based inhibitors, but they are more environmentally friendly, which has practical advantages for use in a broad range of commercial applications.

公开(公告)号：US20230030968A1

公开(公告)日：2023-02-02

申请号：US17878258

申请日：2022-08-01

Applicant: University of Houston System

Inventor： Jeffrey D. Rimer ,  Xi Geng ,  Ricardo Sosa

IPC: C02F5/10

Abstract: Analogues of citrate, namely hydroxycitrate (HCA) and isocitrate (ICA), have dual roles as nucleation inhibitors and growth suppressors in the formation of mineral scale. Their potency is comparable to commercial phosphorous-based inhibitors, but they are more environmentally friendly, which has practical advantages for use in a broad range of commercial applications.